Table of Content

Open Access iconOpen Access

ARTICLE

Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer

Lulin Zhang, Jun Yao, Wenyao Li, Ce Zhang

Department of Oncology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan, P.R. China

Oncology Research 2018, 26(6), 827-836. https://doi.org/10.3727/096504017X14934840662335

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer deaths due to its highly aggressive biological nature and resistance to chemotherapy. Previous studies indicate that miR-21 is an important regulator in the activation of cancer-associated fibroblasts (CAFs). However, whether miR-21 in CAFs would regulate PDAC’s tumor microenvironment and lead to drug resistance remain unknown. In this study, we evaluated the relationship between CAF activation, miR-21 expression, and drug resistance using tumor samples from PDAC patients. We changed the miR-21 expression level in CAFs and tested its roles in regulating the function of CAFs. In addition, we explored the roles of miR-21 in CAFs in the development of PDAC using an animal model. We found that PDAC patients who were resistant to gemcitabine treatment tended to have higher miR-21 expression and more activated CAFs. An in vitro study showed that CAFs with high miR-21 expression had elevated MMP-3, MMP-9, PDGF, and CCL-7 expression and promoted the invasion of PDAC cell lines. miR-21 overexpression also contributed to the activation of CAFs by regulating the PDCD4 gene. The in vivo study showed that upregulating miR-21 in CAFs promoted PDAC desmoplasia and increased its drug resistance to gemcitabine treatment, but downregulating miR-21 in CAFs suppressed desmoplasia and enhanced the effect of gemcitabine. We concluded that miR-21 promoted the activation of CAFs and contributed to the drug resistance of PDAC.

Keywords


Cite This Article

APA Style
Zhang, L., Yao, J., Li, W., Zhang, C. (2018). Micro-rna-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer. Oncology Research, 26(6), 827-836. https://doi.org/10.3727/096504017X14934840662335
Vancouver Style
Zhang L, Yao J, Li W, Zhang C. Micro-rna-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer. Oncol Res. 2018;26(6):827-836 https://doi.org/10.3727/096504017X14934840662335
IEEE Style
L. Zhang, J. Yao, W. Li, and C. Zhang "Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer," Oncol. Res., vol. 26, no. 6, pp. 827-836. 2018. https://doi.org/10.3727/096504017X14934840662335



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 30

    View

  • 38

    Download

  • 0

    Like

Share Link